CellDetect is an innovative diagnostic platform for early cancer detection.
Relying on both color and morphology to differentiate between normal and cancer cells, CellDetect dramatically enhances the diagnostic accuracy of early stage tumors which may be missed by standard staining techniques.
Using a proprietary plant extract and generic dyes, CellDetect colors the nuclei of neoplastic cells in reddish-purple while normal cells are counter-stained with green. The technology is applicable to both urine specimens and cervical smears. It conveniently applies standard laboratory processes for manual and automated slide staining.
CellDetect has been clinically validated on hundreds of cases, demonstrating high sensitivity across all cancer grades and stages. The technology is protected by strong intellectual property including granted and pending patents in the U.S., Europe, China and additional territories.
CellDetect® is a registered trademark of Zetiq Technologies, a fully-owned subsidiary of Micromedic. Both companies comply with ISO 13485-2003 certification.